Add BrightSurf on Google Email

Mayo Clinic


Mayo Clinic news briefs

A Mayo Clinic study finds an association between estrogen status and reduced coronary calcium and plaque area, suggesting a potential benefit against heart disease. Estrogen may modulate the calcium content of atherosclerotic plaques, slowing progression of atherosclerosis in women.

SourceMayo Clinic·JournalJournal of Endocrinology and Metabolism·DateMar 13, 2002

Mayo Clinic study defines patients at greater risk for developing multiple myeloma and related bone marrow cancers

The Mayo Clinic study found that the risk of progression from MGUS to multiple myeloma or related cancers is approximately one percent per year, with larger M-protein levels increasing the risk. Patients with very small protein levels had a 14% progression rate at 20 years, while those with high levels had a 60% progression rate.

SourceMayo Clinic·JournalNew England Journal of Medicine·DateFeb 22, 2002

Mayo Clinic Proceedings looks at epidemic of obesity in February issue

The study, conducted in Olmsted County, Minnesota, found that only a small percentage of people utilize recommended approaches to weight loss. The efforts being undertaken by CardioVision 2020 aim to reduce cardiovascular disease burden through diet and exercise changes. Meanwhile, another study on breast cancer patients highlights the...

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateFeb 12, 2002

Antidepressant provides a cool choice for hot flashes

A recent study by Mayo Clinic researchers has confirmed that long-term use of venlafaxine provides women with breast cancer significant relief from hot flashes, with a 60% reduction in frequency over eight weeks. The antidepressant is considered a safe and effective non-hormonal alternative to estrogen for treating hot flashes.

SourceMayo Clinic·JournalOncology Nursing Forum·DateFeb 12, 2002

Marijuana-derived drug less effective than standard drug for improving appetite and weight in patients with advanced cancer

A study published by the Mayo Clinic found that megestrol acetate was more effective than dronabinol in improving appetite and weight loss in patients with advanced cancer. The study, which evaluated 469 patients, showed that 75% of those taking megestrol acetate reported appetite improvement, compared to 49% of those taking dronabinol.

SourceMayo Clinic·JournalJournal of Clinical Oncology·DateJan 25, 2002

Study finds that steroids soothe sore throat pain

Researchers found that steroid treatment reduced sore throat pain by four hours and increased relief to twice that of placebo patients. The study also showed significant cost savings due to the pill form, which eliminates the need for a physician or nurse to administer the shot.

SourceMayo Clinic·JournalThe Laryngoscope·DateJan 2, 2002

Mayo Clinic study finds prophylactic mastectomy reduces breast cancer risk in highest-risk group of women — carriers of BRCA1 and BRCA2 mutations

A Mayo Clinic study found that prophylactic mastectomy reduced the risk of breast cancer in women with BRCA1 and BRCA2 mutations by 89.5% to 100%. The study followed 26 high-risk women for 13.4 years without developing breast cancer, despite predicted risks of 6-9 cases.

SourceMayo Clinic·JournalJNCI Journal of the National Cancer Institute·DateNov 6, 2001

New study from the United Nations Food and Agricultural Organization and Mayo Clinic sets the stage for future nutritional research throughout the world

A new study from the United Nations Food and Agricultural Organization and Mayo Clinic found that women in western Africa need more energy than men based on their work burden. The research determined that women worked two to three hours more per day than men, resulting in a 30% increase in energy needs.

SourceMayo Clinic·JournalScience·DateOct 25, 2001

Study finds older patients benefit as much from chemotherapy after surgery for colon cancer as younger patients

A new study published in New England Journal of Medicine found that age alone should not determine whether an older patient is offered chemotherapy after surgery for treatment of stage II and III colon cancer. The study showed a significant reduction in death risk and improved survival rates among patients over 70 with the disease.

SourceMayo Clinic·JournalNew England Journal of Medicine·DateOct 10, 2001

Tobacco-industry sponsored research misled

Researchers from Mayo Clinic and University of Minnesota found that tobacco industry sponsored research misled the public about the health risks of secondhand smoke. The study analyzed over 1.5 million pages of internal documents, revealing a campaign by the industry to deny health risks and preserve profits.

SourceMayo Clinic·JournalAmerican Journal of Public Health·DateSep 27, 2001

August news briefs

A Mayo Clinic study published in Cancer journal reveals that daily alcohol consumption by women whose mothers, sisters or daughters have breast cancer may increase their risk for getting the cancer. The study found an increased risk among first-degree relatives of women with breast cancer, but less evidence among second-degree relatives.

SourceMayo Clinic·JournalCancer·DateAug 10, 2001

New Mayo Clinic study questions benefit of smoking reduction

A new Mayo Clinic study found that heavy smokers who cut back their smoking rate may not see health benefits, contradicting the assumption that reducing smoking can lead to better health. The study of 23 heavy smokers over nine weeks showed mixed results, with some biomarkers improving and others worsening.

SourceMayo Clinic·JournalNicotine & Tobacco Research·DateDec 21, 2000

In an animal study, Mayo clinic researchers identify ways to delay and increase survival from Lou Gehrig’s disease

Researchers discovered a modified antioxidant enzyme that delayed onset and increased survival of mice with familial amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The study found that the polyamine-modified catalase better penetrated the blood-brain barrier, reducing levels of hydrogen peroxide and nitric oxide.

SourceMayo Clinic·JournalAnnals of Neurology·DateDec 17, 2000

Less radical surgery for kidney cancer is equally effective to radical alternativve and less likely to cause failure to other kidney

A Mayo Clinic study finds that less radical surgery for kidney cancer is equally effective to radical alternative and less likely to cause failure in the second kidney. Long-term survival rates between the two procedures were identical, but patients undergoing less radical surgery had a lower risk of developing renal failure.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateDec 13, 2000